Nundina › Découvrir les calendriers › Calendrier Dates de décision PDUFA de la FDA › PDUFA date: ARIKAYCE (amikacin liposome inhalation suspension) (Insmed)PDUFA date: ARIKAYCE (amikacin liposome inhalation suspension) (Insmed)28 janvier 2027FDA PDUFA target action date for ARIKAYCE (amikacin liposome inhalation suspension), a NDA from Insmed. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.Calendrier Dates de décision PDUFA de la FDAAutres dates de ce calendrier

26 octobre 2026 - PDUFA date: bepirovirsen (GSK)

29 octobre 2026 - PDUFA date: ILUMYA (tildrakizumab-asmn) (Sun Pharmaceutical Industries)

30 octobre 2026 - PDUFA date: INO-3107 (INOVIO Pharmaceuticals)

1 novembre 2026 - PDUFA date: mitapivat (Agios Pharmaceuticals)

14 novembre 2026 - PDUFA date: MYQORZO (aficamten) (Cytokinetics)